Palivizumab Prophylaxis Against Respiratory Syncytial Virus Infection in Children with Immunocompromised Conditions or Down Syndrome: A Multicenter, Post-Marketing Surveillance in Japan

OBJECTIVE: The aim of this study was to assess the safety and effectiveness of palivizumab for the prevention of lower respiratory tract infection (LRI) caused by respiratory syncytial virus (RSV) in children with immunocompromised conditions or Down syndrome. METHODS: In this multicenter, post-mark...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashiwagi, Tomoko, Okada, Yukiko, Nomoto, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775975/
https://www.ncbi.nlm.nih.gov/pubmed/28895096
http://dx.doi.org/10.1007/s40272-017-0264-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775975/
https://www.ncbi.nlm.nih.gov/pubmed/28895096
http://dx.doi.org/10.1007/s40272-017-0264-y

Ejemplares similares